经皮内镜辅助下经椎间孔腰椎减压融合术和传统开放手术治疗腰椎退行性疾病的多中心前瞻性随机对照研究

注册号:

Registration number:

ChiCTR1900020679 

最近更新日期:

Date of Last Refreshed on:

2019-01-13 08:09:57 

注册时间:

Date of Registration:

2019-01-13 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

经皮内镜辅助下经椎间孔腰椎减压融合术和传统开放手术治疗腰椎退行性疾病的多中心前瞻性随机对照研究

Public title:

A multicenter randomized controlled trial for percutaneous endoscope transforaminal lumbar interbody fusion (PE-TLIF) and traditional open surgery for the treatment of degenerative diseases of the lumbar spine

注册题目简写:

English Acronym:

研究课题的正式科学名称:

经皮内镜辅助下经椎间孔腰椎减压融合术和传统开放手术治疗腰椎退行性疾病的多中心前瞻性随机对照研究

Scientific title:

A multicenter randomized controlled for percutaneous endoscope transforaminal lumbar interbody fusion (PE-TLIF) and traditional open surgery for the treatment of degenerative diseases of the lumbar spine

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

杨晋才 

研究负责人:

杨晋才 

Applicant:

Jin-Cai Yang 

Study leader:

Jin-Cai Yang 

申请注册联系人电话:

Applicant telephone:

+86 13910289665

研究负责人电话:

Study leader's
telephone:

+86 13910289665

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

jincaiy2008@163.com

研究负责人电子邮件:

Study leader's E-mail:

jincaiy2008@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

北京市朝阳区工体南路8号

研究负责人通讯地址:

北京市朝阳区工体南路8号

Applicant address:

8 Worker Stadium Road South, Chaoyang District, Beijing, China

Study leader's address:

8 Worker Stadium Road South, Chaoyang District, Beijing, China

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

首都医科大学附属北京朝阳医院

Applicant's institution:

Beijing Chao-Yang Hospital

研究负责人所在单位:

首都医科大学附属北京朝阳医院

Affiliation of the Leader:

Beijing Chao-Yang Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

2016-科-187-1

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

首都医科大学附属朝阳医院伦理委员会

Name of the ethic committee:

Ethics committee of Chaoyang Hospital Affiliated to Capital Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

1990-01-01 00:00:00

伦理委员会联系人:

杨晋才

Contact Name of the ethic committee:

Jin-Cai Yang

伦理委员会联系地址:

北京市朝阳区工体南路8号

Contact Address of the ethic committee:

8 Worker Stadium Road South, Chaoyang District, Beijing, China

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

杨晋才

Primary sponsor:

Jin-Cai Yang

研究实施负责(组长)单位地址:

北京市朝阳区工体南路8号

Primary sponsor's address:

8 Worker Stadium Road South, Chaoyang District, Beijing, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

北京市

市(区县):

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京朝阳医院

具体地址:

北京市朝阳区工体南路8号

Institution
hospital:

Beijing Chao-Yang Hospital

Address:

8 Worker Stadium Road South, Chaoyang District, Beijing, China

经费或物资来源:

课题项目

Source(s) of funding:

project of the subject

研究疾病:

腰椎退行性疾病  

Target disease:

Lumbar degenerative disease

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

前瞻性研究腰椎新手术技术治疗腰椎退行性疾病的可行性、疗效及安全性。  

Objectives of Study:

To prospectively study the feasibility, efficacy and safety of new surgical techniques for the treatment of lumbar degenerative diseases

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

不能耐受手术的患者; 凝血性障碍患者; Ⅱ°以上腰椎滑脱; 腰椎不稳并有明显的腰痛,VAS评分大于5分 发育性腰椎管狭窄症; 影像学显示重度腰椎管狭窄症; 伴有全身疾病不能接受全身麻醉者; 合并其它疾病有手术禁忌症者。 活跃性感染患者。

Exclusion criteria:

1. patients who cannot tolerate surgery;
2. patients with coagulopathy;
3. lumbar spondylolisthesis above 2 degrees;
4. lumbar instability and significant lumbago, with VAS scores greater than 5;
5. developmental lumbar spinal stenosis;
6. imaging showed severe lumbar spinal stenosis;
7. patients with systemic disease who cannot receive general anesthesia;
8. patients who have surgical contraindications for other diseases;
9. active infection.

研究实施时间:

Study execute time:

From 2019-01-01 00:00:00 To 2020-12-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2019-01-01 00:00:00 To 2020-12-01 00:00:00

干预措施:

Interventions:

组别:

微创组

样本量:

100

Group:

minimally invasive group

Sample size:

干预措施:

经皮内镜下经椎间孔腰椎减压融合术

干预措施代码:

Intervention:

PE-TLIF

Intervention code:

组别:

对照组

样本量:

100

Group:

control group

Sample size:

干预措施:

开放手术

干预措施代码:

Intervention:

open operation

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

北京市 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京朝阳医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

Beijing Chao-Yang Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

重庆 

市(区县):

 

Country:

China

Province:

Chongqing

City:

单位(医院):

陆军军医大学新桥医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

Xin-Qiao Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

湖南 

市(区县):

 

Country:

China

Province:

Hunan

City:

单位(医院):

中南大学湘雅二医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

THE SECOND XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSIT

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

四川 

市(区县):

 

Country:

China

Province:

Szechwan

City:

单位(医院):

四川大学华西医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

West China Hospital,Sichuan University

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China

Province:

Guangdong

City:

单位(医院):

中山大学附属第三医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

.THE THIRD AFFILATED HOSPITAL, SUN YAT-SEN UNIVERSITY

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

空军军医大学唐都医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

TANGDU HOOSPITAL

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

山西 

市(区县):

 

Country:

China

Province:

Shanxi

City:

单位(医院):

山西省人民医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

Shanxi Provincial People's Hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

内蒙古自治区 

市(区县):

 

Country:

China

Province:

Inner Mongolia Autonomous Region

City:

单位(医院):

内蒙古医科大学第二附属医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

The second affiliated hospital of Inner Mongolia medical university

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

辽宁 

市(区县):

 

Country:

China

Province:

Liaoning

City:

单位(医院):

大连医科大学附属第一医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

The first affiliated hospital of dalian medical university

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

北京市 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

中国人民解放军总医院第一附属医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

The first affiliated hospital of the PLA general hospital

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

北京市 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

北京大学第三医院海淀医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

BEIJING HAIDIAN HOSPITAL

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

湖北 

市(区县):

 

Country:

China

Province:

Hubei

City:

单位(医院):

湖北省宜昌市中心人民医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

Central People's Hospital of Yichang City, Hubei Province

Level of the institution:

Tertiary A Hospital

国家:

中国

省(直辖市):

陕西 

市(区县):

 

Country:

China

Province:

Shaanxi

City:

单位(医院):

陕西省宝鸡市中医医院 

单位级别:

国家级综合三甲医院 

Institution
hospital:

Shaanxi Baoji Traditional Chinese Medicine Hospital

Level of the institution:

Tertiary A Hospital

测量指标:

Outcomes:

指标中文名:

疼痛评分

指标类型:

主要指标

Outcome:

VAS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

功能障碍评分

指标类型:

主要指标

Outcome:

ODI

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

融合率

指标类型:

主要指标

Outcome:

fusion rate

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

椎间盘

组织:

Sample Name:

intervetebral disc

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

杨晋才使用随机数表法根据奇数偶数选择手术方式

Randomization Procedure (please state who generates the random number sequence and by what method):

Yang jincai choose the operation method according to the random number table method

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

未说明

Blinding:

Not stated

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

国家人口与健康科学数据共享服务平台—临床医学科学数据中心

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

National population and health science data sharing service platform-clinical medical science data center

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

病例记录表 Resman

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

case report Resman

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2019-01-13 08:09:57